Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microtubule-associated protein tau (MAPT) is a neuronal protein that stabilizes microtubules and regulates axonal transport. Phosphorylation regulates tau's function; hyperphosphorylation leads to detachment from microtubules, aggregation into neurofibrillary tangles, and neurodegeneration in Alzheimer's disease and other tauopathies. Key phosphorylation sites include Ser199/Ser202/Thr205, Thr212, Thr231/Ser235, Ser262/Ser356, Ser396/Ser404, and Ser422. Kinases such as MARKs phosphorylate tau. Mutations can promote increased phosphorylation rates.
Kinase inhibition to reduce tau phosphorylation, promotion of microtubule stabilization, inhibition of tau aggregation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microtubule-associated protein tau (Phosphorylated) (None specified).